Ipamorelin
Growth hormone & endocrine
Early humanResearch includes pituitary cell, rat, and swine pharmacology and a registered human postoperative gastrointestinal function study.
Limited, exploratory, early phase or small human studies have been identified.
What is Ipamorelin?
Ipamorelin is a synthetic growth hormone secretagogue peptide acting at the ghrelin receptor used in pituitary and endocrine research; the catalogue label denotes research grade ipamorelin employed in cell, animal and selected human studies.
Which research context has Ipamorelin been associated with?
Ipamorelin is associated with growth hormone and endocrine research as a synthetic ghrelin receptor agonist peptide, investigated in pituitary cell, rodent and swine pharmacology studies and a registered human trial assessing postoperative gastrointestinal function.
What documentation is available for Ipamorelin?
Ipamorelin: Batch documents are not yet linked on this site. Required evidence for this synthetic ghrelin receptor agonist peptide includes batch identifier and release date; identity by liquid chromatography mass spectrometry/intact mass and sequence confirmation; analytical HPLC/UPLC chromatogram with method and purity specification; peptide content, counterion and residual solvent/water details; and potency or release assay documentation. No batch documentation is shown as available until the record for that specific item is linked and reviewed.
What determines the storage conditions for Ipamorelin?
Ipamorelin: Storage depends on the documented supplied presentation; as a synthetic ghrelin receptor agonist peptide verify whether supplied dry/lyophilised or in solution, counterion and concentration, solvent or buffer composition, pH, container closure compatibility and freeze/thaw tolerance that affect aggregation and chemical stability. No storage instruction is shown as available until the stability record for that specific item is linked and reviewed.